CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Warszawa, Poland and 125 other locations
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Warszawa, Poland and 213 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Warszawa, Poland and 176 other locations
Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...
Phase 3
Warszawa, Poland and 202 other locations
The primary objective is to evaluate in participants with high-grade serous ovarian cancer (HGSOC), whether the reduction from base...
Phase 2
Warszawa, Mazowieckie, Poland and 44 other locations
in participants with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer...
Phase 3
Warszawa, Poland and 213 other locations
activity in participants with advanced metastatic colorectal cancer, ovarian cancer, renal cancer or pancreatic c....
Phase 1
Warsaw, Mazowieckie, Poland and 2 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Warsaw, Kondratowicza, Poland and 237 other locations
survival (PFS) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as assessed by the investigator. The hypotheses are that pembro...
Phase 3
Warszawa, Mazowieckie, Poland and 186 other locations
and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary perito...
Phase 3
Warszawa, Mazowieckie, Poland and 226 other locations
Clinical trials
Research sites
Resources
Legal